Bruce Burlington
InvestorM.D. at ATEM Capital Fund
Find your path to Bruce
Sign up to see every warm intro you have to Bruce
- Paths you didn't know you had: your email and LinkedIn already hold routes to Bruce. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Independent consultant on pharmaceutical development and regulatory affairs with over 30 years of experience. He held senior regulatory roles at Wyeth and served 17 years at the FDA, and sits on the boards of AstraZeneca and Cangene.
Colleagues at ATEM Capital Fund
Allan Gobbs
Managing Partner at ATEM Capital Fund
Dmitry Kobyzev
Managing Partner at ATEM Capital Fund
Ed Godber
Advisory Board at ATEM Capital Fund
Elena Maley
Managing Partner at ATEM Capital Fund
Ilia Ardabevskii
Principal at ATEM Capital Fund
Ilya Yasny
Managing Partner, Head of Scientific Research at ATEM Capital Fund
Joseph Camardo
Advisory Board at ATEM Capital Fund
Rivka Kreitman
Advisory Board at ATEM Capital Fund
Frequently asked questions
- Who is Bruce Burlington?
- Independent consultant on pharmaceutical development and regulatory affairs with over 30 years of experience. He held senior regulatory roles at Wyeth and served 17 years at the FDA, and sits on the boards of AstraZeneca and Cangene.
- Where does Bruce Burlington work?
- Bruce Burlington is M.D. at ATEM Capital Fund.
About this profile. Compiled from public sources — ATEM Capital Fund's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








